Nicolet Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$312K Buy
2,542
+215
+9% +$26.1K 0.02% 319
2025
Q3
$272K Buy
2,327
+65
+3% +$7.39K 0.02% 335
2025
Q2
$256K Buy
2,262
+120
+6% +$12.8K 0.02% 341
2025
Q1
$217K Sell
2,142
-1,438
-40% -$148K 0.02% 346
2024
Q4
$322K Buy
3,580
+100
+3% +$9K 0.03% 277
2024
Q3
$293K Sell
3,480
-214
-6% -$16.3K 0.03% 292
2024
Q2
$254K Buy
3,694
+753
+26% +$50.3K 0.02% 308
2024
Q1
$206K Buy
2,941
+336
+13% +$25.8K 0.02% 334
2023
Q4
$217K Buy
+2,605
New +$203K 0.02% 298
2023
Q3
Sell
-2,680
Closed -$204K 319
2023
Q2
$204K Buy
+2,680
New +$214K 0.02% 295
2020
Q2
Sell
-3,190
Closed -$239K 209
2020
Q1
$239K Buy
+3,190
New +$220K 0.04% 160

Other funds holding GILD

Nicolet Advisory Services's GILD Position: Q4 2025 in Review

Nicolet Advisory Services increased its Gilead Sciences (GILD) stake by 9.2% in Q4 2025, buying an estimated $26.1K and bringing the position to 2,542 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #319.

Nicolet Advisory Services first reported a position in GILD in Q1 2020 and has held it in 11 quarters since. The position peaked at $322K in Q4 2024. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Nicolet Advisory Services held 2,542 shares of Gilead Sciences worth $312K as of Q4 2025.
  • Nicolet Advisory Services bought 215 Gilead Sciences shares in Q4 2025, an estimated $26.1K.
  • Gilead Sciences made up 0.02% of Nicolet Advisory Services's portfolio in Q4 2025, its #319 holding.
  • Nicolet Advisory Services first reported a position in Gilead Sciences in Q1 2020 and has held it in 11 quarters since.
  • Nicolet Advisory Services's Gilead Sciences position peaked at $322K in Q4 2024.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.